CN115024994B - High-safety sun-screening composition and preparation method and application thereof - Google Patents
High-safety sun-screening composition and preparation method and application thereof Download PDFInfo
- Publication number
- CN115024994B CN115024994B CN202210593580.4A CN202210593580A CN115024994B CN 115024994 B CN115024994 B CN 115024994B CN 202210593580 A CN202210593580 A CN 202210593580A CN 115024994 B CN115024994 B CN 115024994B
- Authority
- CN
- China
- Prior art keywords
- sun
- sunscreen
- sunscreen composition
- dimethicone
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 238000012216 screening Methods 0.000 title abstract description 18
- 239000000516 sunscreening agent Substances 0.000 claims abstract description 71
- 230000000475 sunscreen effect Effects 0.000 claims abstract description 56
- 239000002537 cosmetic Substances 0.000 claims abstract description 35
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims abstract description 30
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000011787 zinc oxide Substances 0.000 claims abstract description 15
- 239000004408 titanium dioxide Substances 0.000 claims abstract description 14
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 11
- 238000002156 mixing Methods 0.000 claims abstract description 9
- 239000004615 ingredient Substances 0.000 claims abstract description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 24
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 24
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 21
- 229940008099 dimethicone Drugs 0.000 claims description 17
- -1 diethyl hexyl butyramide triazinone Chemical compound 0.000 claims description 13
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 230000004888 barrier function Effects 0.000 claims description 8
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N benzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 claims description 8
- 239000003995 emulsifying agent Substances 0.000 claims description 8
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 8
- 239000002562 thickening agent Substances 0.000 claims description 8
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 8
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 claims description 7
- 239000006071 cream Substances 0.000 claims description 7
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 claims description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 claims description 6
- 239000006210 lotion Substances 0.000 claims description 6
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 claims description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 5
- 239000003906 humectant Substances 0.000 claims description 5
- 239000003002 pH adjusting agent Substances 0.000 claims description 5
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 239000004743 Polypropylene Substances 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- 229920001155 polypropylene Polymers 0.000 claims description 4
- 239000004475 Arginine Substances 0.000 claims description 3
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 3
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 claims description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 3
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 claims description 3
- 229910000271 hectorite Inorganic materials 0.000 claims description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- MSRJTTSHWYDFIU-UHFFFAOYSA-N octyltriethoxysilane Chemical compound CCCCCCCC[Si](OCC)(OCC)OCC MSRJTTSHWYDFIU-UHFFFAOYSA-N 0.000 claims description 3
- 229960003493 octyltriethoxysilane Drugs 0.000 claims description 3
- 229940061571 peg-9 dimethicone Drugs 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- UUJLHYCIMQOUKC-UHFFFAOYSA-N trimethyl-[oxo(trimethylsilylperoxy)silyl]peroxysilane Chemical compound C[Si](C)(C)OO[Si](=O)OO[Si](C)(C)C UUJLHYCIMQOUKC-UHFFFAOYSA-N 0.000 claims description 3
- 239000002738 chelating agent Substances 0.000 claims description 2
- 230000003750 conditioning effect Effects 0.000 claims description 2
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical group CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 claims description 2
- 239000003205 fragrance Substances 0.000 claims description 2
- YZUUTMGDONTGTN-UHFFFAOYSA-N nonaethylene glycol Chemical group OCCOCCOCCOCCOCCOCCOCCOCCOCCO YZUUTMGDONTGTN-UHFFFAOYSA-N 0.000 claims description 2
- 230000002829 reductive effect Effects 0.000 abstract description 6
- 239000002250 absorbent Substances 0.000 abstract description 4
- 230000002745 absorbent Effects 0.000 abstract description 4
- 231100000252 nontoxic Toxicity 0.000 abstract description 3
- 230000003000 nontoxic effect Effects 0.000 abstract description 3
- 238000006243 chemical reaction Methods 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 32
- 230000037072 sun protection Effects 0.000 description 24
- 230000000052 comparative effect Effects 0.000 description 16
- 239000012071 phase Substances 0.000 description 16
- 230000002087 whitening effect Effects 0.000 description 10
- 239000003974 emollient agent Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- SHZIWNPUGXLXDT-UHFFFAOYSA-N ethyl hexanoate Chemical compound CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000006096 absorbing agent Substances 0.000 description 7
- 210000004080 milk Anatomy 0.000 description 6
- 235000013336 milk Nutrition 0.000 description 6
- 230000004224 protection Effects 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 229940099549 polyglycerin-3 Drugs 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- XTJFFFGAUHQWII-UHFFFAOYSA-N Dibutyl adipate Chemical compound CCCCOC(=O)CCCCC(=O)OCCCC XTJFFFGAUHQWII-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 206010051246 Photodermatosis Diseases 0.000 description 2
- 208000000453 Skin Neoplasms Diseases 0.000 description 2
- 206010042496 Sunburn Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- SWQUTKGVXGTROS-UHFFFAOYSA-N bis(2-ethoxyethyl) butanedioate Chemical compound CCOCCOC(=O)CCC(=O)OCCOCC SWQUTKGVXGTROS-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 229940100539 dibutyl adipate Drugs 0.000 description 2
- 229940119676 diethoxyethyl succinate Drugs 0.000 description 2
- 229940031569 diisopropyl sebacate Drugs 0.000 description 2
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 description 2
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 2
- 229940102552 disteardimonium hectorite Drugs 0.000 description 2
- SRVSYCCHRDXMMS-UHFFFAOYSA-N dodecan-5-yl 2-hydroxybenzoate Chemical compound CCCCCCCC(CCCC)OC(=O)C1=CC=CC=C1O SRVSYCCHRDXMMS-UHFFFAOYSA-N 0.000 description 2
- XJFGDLJQUJQUEI-UHFFFAOYSA-N dodecyl decanoate dodecyl octanoate Chemical compound CCCCCCCCCCCCOC(=O)CCCCCCC.CCCCCCCCCCCCOC(=O)CCCCCCCCC XJFGDLJQUJQUEI-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 2
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 2
- 229940074928 isopropyl myristate Drugs 0.000 description 2
- 229940075495 isopropyl palmitate Drugs 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000037368 penetrate the skin Effects 0.000 description 2
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 2
- 230000008845 photoaging Effects 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 201000000849 skin cancer Diseases 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 1
- PFHLGILELJGQSJ-UHFFFAOYSA-N 4-(2h-benzotriazol-4-ylmethyl)-2h-benzotriazole;2-butyl-3,4,5,6-tetramethylphenol Chemical compound CCCCC1=C(C)C(C)=C(C)C(C)=C1O.C=1C=CC=2NN=NC=2C=1CC1=CC=CC2=C1N=NN2 PFHLGILELJGQSJ-UHFFFAOYSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- QQQVMDXJEAGNQT-UHFFFAOYSA-N N-octan-3-ylbutanamide Chemical compound C(CCC)(=O)NC(CCCCC)CC QQQVMDXJEAGNQT-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 241000727169 Prinsepia utilis Species 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 229940024874 benzophenone Drugs 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 125000000853 cresyl group Chemical group C1(=CC=C(C=C1)C)* 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229960002086 dextran Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- SOQBVABWOPYFQZ-UHFFFAOYSA-N oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[Ti+4] SOQBVABWOPYFQZ-UHFFFAOYSA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229940057874 phenyl trimethicone Drugs 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 description 1
- 229940124543 ultraviolet light absorber Drugs 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4966—Triazines or their condensed derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
The invention belongs to the field of cosmetics, and relates to a high-safety sun-screening composition, and a preparation method and application thereof. The personal care sunscreen composition is formed by mixing one or a combination of macromolecular organic ultraviolet absorbent, inorganic ultraviolet screening agent titanium dioxide and zinc oxide and other cosmetically acceptable ingredients, is safe and nontoxic, and can perform photo-thermal conversion on the absorbed ultraviolet while scattering the ultraviolet; in addition, the macromolecular organic ultraviolet absorbent has better light stability, safety and high efficiency, so that the cosmetics are easy to spread and disperse, the sticky feeling is reduced, and the application field of the cosmetics is enlarged.
Description
Technical Field
The invention belongs to the field of cosmetics, and in particular relates to a high-safety type sun-screening composition and a preparation method and application thereof.
Background
Ultraviolet light is the main focus of research for current stage photoaging. Ultraviolet light is divided into three bands UVA, UVB, UVC. Wherein UVC is almost completely absorbed by the ozone layer and cannot reach the earth's surface. UVA is ultraviolet with a wavelength of 280-320nm, and most of UVA is absorbed by skin epidermis, and can denature nucleic acid or protein in skin surface cells, reddish skin, erythema (sunburn) and acute dermatitis, which is commonly called sunburn. The magnitude of the sun protection factor SPF (Sun Protection Factor) value is generally used to evaluate the resistance of sun protection cosmetics to UVB. Skin cancer is also easily caused by excessive ultraviolet radiation. UVA is ultraviolet with the wavelength of 320-400nm, has strong penetrating power, can reach the dermis layer of skin, destroy collagen and elastin of skin, cause the generation of wrinkles, the damage is cumulative, is a main cause of photoaging, and simultaneously stimulates melanin generation, so that the skin color is uneven. The sun protection cosmetic is generally evaluated for its resistance to UVA by a sun protection factor PA (Protection UVA).
Sunscreens used in cosmetics on the market at present are mainly classified into organic ultraviolet absorbers and inorganic ultraviolet screening agents. Inorganic ultraviolet screening agents, which are recognized by national security, mainly include titanium dioxide and zinc oxide, and the types and maximum addition amounts of organic ultraviolet screening agents are limited differently from country to country. Inorganic ultraviolet screening agents are considered to be non-toxic and safe to the human body. The sunscreen cosmetic has no irritation to skin and no cancer, but the sunscreen cosmetic is whitish and thick and heavy due to the addition of a large amount of titanium dioxide and zinc oxide, is difficult to disperse a coating film, and has poor experience of consumers.
Although skin is a barrier, it is not completely impermeable and molecules of sufficiently small molecular weight can penetrate the skin layer and then be absorbed, this amount typically being considered to be 500 daltons. There are no effective topical drugs with molecular weights exceeding 500 daltons and almost all known allergens are below 500 daltons. Although sunscreen products using organic UV absorbers can provide a refreshing skin feel, related studies have demonstrated that some small molecular weight organic UV absorbers (e.g., avobenzone, octocrylene, benzophenone) can penetrate the skin into the blood and present a significant safety hazard during use by humans. Safety is the biggest limiting factor in the use of sunscreens, and macromolecular sunscreens have greatly improved safety compared to small molecule sunscreens, and organic small molecule sunscreens have proven to have potential safety risks (disrupting endocrine, inducing congenital giant intestinal segments in infants, etc.). Based on this theory, only high molecular weight chemical sunscreens were selected to reduce skin irritation when developing sunscreen products.
The skin becomes dry and rough immediately after being damaged by ultraviolet irradiation, and loses elasticity and luster. Therefore, sun protection is of paramount importance. The desert muscle is the skin with rough, reddish-hot and desquamation symptoms, and the skin is dry like a desert, and is mainly caused by long-term injury accumulation, such as frequent insolation, careless maintenance, frequent exfoliating and the like. The skin is extremely sensitive, especially exposed to sunlight, and is easy to be stimulated by the outside to generate cell inflammation, so that normal physiological functions of the skin such as self-repairing and updating can be influenced, and certain destructive factors can be generated, so that the skin is damaged, the dryness is further worsened, and the aging process of the skin is accelerated.
Under the premise of ensuring the sun-screening effect, the modern sun-screening technology generally needs to add a large amount of small molecular organic sun-screening agents, and light instability, irritation and safety risks possibly exist, so that the development of macromolecular mild sun-screening cosmetics suitable for sensitive muscles and desert muscles is important. However, since the organic sunscreen agent having a large molecular weight is basically crystalline, it is easily crystallized in the formulation system, and the solubility thereof is a problem to be solved by the present invention.
Disclosure of Invention
In one aspect, the present application provides a sunscreen composition comprising, by weight:
0.1-10% of diethyl hexyl butyramide triazinone and 0.1-10% of bis-ethylhexyl oxyphenol methoxyphenyl triazine.
In some embodiments, the sunscreen composition further comprises the following materials in weight percent: polysiloxane-150.1-10%, ethylhexyl triazone 0.1-5%.
In some embodiments, the sunscreen composition further comprises a physical sunscreen agent; in some embodiments, the physical sunscreens are selected from one or both of zinc oxide or titanium dioxide; in some embodiments, the physical sunscreens are in the sunscreening composition in weight percent: 0.05-20% of zinc oxide and 0.05-20% of titanium dioxide; in some embodiments, the physical sunscreens are surface-treated physical sunscreens; in some embodiments, the surface treatment is a treatment with triethoxyoctylsilane as a surface treating agent.
In some embodiments, the sunscreen composition further comprises one or more of an emulsifier, a film former, an emollient, a thickener, a humectant, a chelating agent, a preservative, a skin conditioning agent, a fragrance, a pH adjusting agent, a solvent.
In some embodiments, the emulsifier is selected from one or more of PEG-9 dimethicone ethyl dimethicone, polyglycerol-3 dimethicone hydroxyethyl dimethicone, lauryl polyethylene glycol/polypropylene glycol-18/18-dimethicone, PEG-10 dimethicone, polyglycerol-3 polyricinoleate, polyglycerol-3 diisostearate; in some embodiments, the emulsifier is selected from the group consisting of PEG-9 polydimethylsiloxane ethyl polydimethylsiloxane and PEG-10 polydimethylsiloxane.
In some embodiments, the film former is selected from one or more of trimethylsiloxysilicate, polyurethane, hydrogenated polycyclopentadiene; in some embodiments, the film former is selected from trimethylsiloxysilicates.
In some embodiments, the emollient is selected from one or more of the group consisting of tri (ethylhexanoate), caprylic/capric triglyceride, pentaerythritol tetra (ethylhexanoate), butyl octanol salicylate, diethoxyethyl succinate, isododecane, cetyl ethylhexanoate, isopropyl myristate, isopropyl palmitate, diisopropyl sebacate, dibutyl adipate, C12-15 alcohol benzoate, dioctyl carbonate, coco-caprylate/caprate, dimethicone, octyl dimethicone, cyclopentadimethicone, phenyl trimethicone; in some embodiments, the emollient is selected from caprylic/capric triglyceride, isopropyl palmitate, C12-15 alcohol benzoate, cyclopentadimethicone; in some embodiments, the weight percent of the emollient in the sunscreen composition is: 0.5-20% of caprylic/capric triglyceride, 0.5-20% of isopropyl palmitate and 0.5-20% of C12-15 alcohol benzoate.
In some embodiments, the thickener is selected from one or more of disteardimonium hectorite, silica silylate, dextrin palmitate; in some embodiments, the thickener is selected from distearyl dimethylammonium hectorite.
In some embodiments, the pH adjuster is selected from one or more of arginine, sodium hydroxide, potassium hydroxide, triethanolamine, aminomethylpropanol.
The application also provides application of the sun-screening composition in preparing cosmetics; in some embodiments, the cosmetic is selected from any one of sun cream, sun lotion, sun cream, sun liquid, sun spray, sun gel, barrier cream, barrier lotion, BB cream.
The application also provides a preparation method of the sun-screening composition, which comprises the step of mixing the components.
The sunscreen cosmetic composition of the present invention is mainly obtained by mixing an oil phase and an aqueous phase and adding other ingredients.
The oil phase mainly comprises an emulsifier, a film forming agent, an emollient, a sun-screening agent and an oil phase thickener, but can also contain other components according to requirements.
The emulsifier is not particularly limited as long as it can form a water-in-oil (W/O) type or oil-in-water (O/W) type emulsified sunscreen cosmetic composition, and for example, PEG-9 dimethicone ethyl dimethicone, polyglycerin-3 dimethicone hydroxyethyl dimethicone, lauryl polyethylene glycol/polypropylene glycol-18/18-dimethicone, PEG-10 dimethicone, polyglycerin-3 polyricinoleate, polyglycerin-3 diisostearate, and the like can be used.
As film forming agents, for example, trimethylsiloxysilicate, polyurethane, hydrogenated polycyclopentadiene, etc. can be used.
As the emollient, an emollient commonly used in the cosmetic field can be used, and is not particularly limited.
Specifically, glycerol tri (ethylhexanoate), caprylic/capric triglyceride, pentaerythritol tetra (ethylhexanoate), butyl octanol salicylate, diethoxyethyl succinate, isododecane, cetyl ethyl hexanoate, isopropyl myristate, isopropyl palmitate, diisopropyl sebacate, dibutyl adipate, C12-15 alcohol benzoate, dioctyl carbonate, coco-caprylate/caprate, polydimethylsiloxane, octyl polymethylsiloxane, cyclopentadimethicone, phenyltrimethylpolysiloxane, and the like can be used.
As sunscreens, organic uv absorbers contain only large molecular weights and have molecular weights greater than 500 daltons, including oil-soluble ones: polysiloxane-15, ethylhexyl triazone, diethyl hexyl butyryl amino triazone, cresyl trazotrisiloxane, bis-ethylhexyl oxyphenol methoxyphenyl triazine, water soluble: disodium phenylbisbenzimidazole tetrasulfonate and organic microparticles: two or more of methylenebis-benzotriazole tetramethylbutylphenol. Inorganic uv blockers titanium dioxide and zinc oxide can be used.
As the oil phase thickener, disteardimonium hectorite, silica silylate, dextrin palmitate and the like can be mentioned.
The water phase comprises humectant, antiseptic, pH regulator, and other components as required.
The humectant is not particularly limited as long as it is a humectant commonly used in the cosmetic field, and examples thereof include glycerin, propylene glycol, seaweed extract, sodium hyaluronate, aloe extract, joba oil, polyethylene glycol/polypropylene glycol-14/7 dimethyl ether, xylitol, sorbitol, and the like.
Examples of the preservative include phenoxyethanol, ethylhexyl glycerol, hexylene glycol, and pentylene glycol.
Examples of the pH adjuster include arginine, sodium hydroxide, potassium hydroxide, triethanolamine, and aminomethylpropanol.
One or more of vitamin E, scutellariae radix extract, bisabolol, scutellariae radix extract, prinsepia utilis extract, ceramide, dextran, and vitamin B5 with damaged skin repairing effect can also be added into sunscreen cosmetic composition.
The organic ultraviolet light absorbers of the present invention are preferably polysiloxane-15, ethylhexyl triazone, diethylhexyl butyrylaminotriazone and bis-ethylhexyl oxyphenol methoxyphenyl triazine.
Wherein the polysiloxane-15, ethylhexyl triazone and ethylhexyl butyryl triazone mainly absorb ultraviolet rays in UVB wave bands, and are used for preventing skin from sun-drying; the bis-ethylhexyloxyphenol methoxyphenyl triazine is the most effective broad-spectrum UV absorber, has shielding effect on ultraviolet rays in UVA wave bands, prevents tanning and induces skin cancer, has larger absorption in the 330-350nm area with weak absorption of other three ultraviolet absorbers, is used for overcoming the defects of other three sun-screening agents, has a synergistic effect, and can obtain more stable and efficient sun-screening effect.
The preferred organic UV absorbers of the present invention are preferably used in amounts relative to sunscreen cosmetic compositions
The total weight is polysiloxane-150.1-10%, ethylhexyl triazone 0.1-5%, ethylhexyl butyramide triazone 0.1-10%, and bis-ethylhexyl oxyphenol methoxyphenyl triazone 0.1-10%.
The emollient of the present application, preferably caprylic/capric triglyceride, isopropyl palmitate, or C12-15 alcohol benzoate, is an excellent solvent for the above sunscreen agent, and can provide an effect of being more stable at low temperatures and not precipitating. Cyclopentadimethicone provides a refreshing skin feel to the compositions of the present application.
Preferred emollients of the present invention are preferably used in amounts relative to the total weight of the sunscreen cosmetic composition: 0.5-20% of caprylic/capric triglyceride, 0.5-20% of isopropyl palmitate and 0.5-20% of C12-15 alcohol benzoate.
The invention further comprises an inorganic uv blocker, preferably zinc oxide, which blocks mainly UVA, and titanium dioxide, which blocks mainly UVB.
The inorganic ultraviolet blocking agent is preferably used in an amount of 0.05 to 20% of zinc oxide and 0.05 to 20% of titanium dioxide relative to the total weight of the sunscreen cosmetic composition.
< Second aspect >
In a second aspect the present invention provides a process for the preparation of a sunscreen composition comprising the step of mixing the components of the sunscreen composition. The preparation method of the sun-proof composition is simple and easy to implement, raw materials are easy to obtain, and the sun-proof composition is suitable for mass production.
In some specific embodiments, the method of making the sunscreen composition comprises the steps of:
dissolving the oil phase and the water phase components at 70-90 ℃, preparing an oil phase and water phase mixture, and uniformly mixing by an Ika T18 homogenizer at 3000-4000 r/min; after cooling to below 45 ℃, other components are added to prepare the sunscreen composition cosmetic.
Further, the invention also provides the use of the sun protection composition according to the invention for sun protection products, such as skin care products and body products, comprising sun protection emulsions, sun protection lotions, sun protection creams, sun protection liquids, sun protection sprays, sun protection gels, barrier creams, barrier milks, barrier lotions, BB creams.
Detailed Description
The technical solution of the present invention is further illustrated by the following specific examples, which do not represent limitations on the scope of the present invention. Some insubstantial modifications and adaptations of the invention based on the inventive concept by others remain within the scope of the invention.
The sunscreen compositions of examples 1-7 were prepared according to the mass percentages of the components in table 1 below.
The preparation method of the sun-screening composition comprises the following steps:
dissolving the oil phase and the water phase components at 70-90 ℃, preparing an oil phase and water phase mixture, and uniformly mixing by an Ika T18 homogenizer at 3000-4000 r/min; after cooling to below 45 ℃, other components are added to prepare the sunscreen composition cosmetic.
Table 1 sunscreen compositions of examples 1-7
According to the following mass percentages of the components in Table 2, the preparation methods of examples 1 to 7 were followed to prepare sunscreen compositions of comparative examples 1 to 6.
Table 2 sunscreen compositions of comparative examples 1-6
Efficacy test
Sun Protection Factor (SPF): also known as the sun protection factor, indicates the level of sun protection efficacy that a sunscreen product can perform. The greater the SPF value, the better the sunscreen effect. It is determined based on the Minimum Erythema Dose (MED) of the skin. The minimum erythema dose of the skin increases after the sun protection product is used, and the sun protection factor SPF of the sun protection product is as follows: SPF = MED of sample protected skin/MED of unprotected skin. The SPF index is suitable for evaluating the protective effect against UVB.
Sunscreen cosmetics long wave ultraviolet protection index (Protection Factor ofUVA, PFA value): also known as UVA protection index. UVA in sunlight irradiates the skin, mainly producing a physiological effect of skin darkening, measured as the minimum sustained blackening amount (MPPD). MPPD is the minimum ultraviolet radiation dose or minimum irradiation time required to produce a slight darkening of the skin over the entire irradiated area 2-4 hours after irradiation. PFA = MPPD of sample protected skin/MPPD of unprotected skin. PFA grading refers to cosmetic label identification management standard specifications.
The evaluation scale is shown in the following Table 3:
TABLE 3 Table 3
Range of PFA values | Identification mark |
PFA<2 | UVA protection effect cannot be identified |
2≤PFA≤3 | Identified as PA + |
4≤PFA≤7 | Identified as PA + |
8≤PFA≤15 | Identified as pa++ + |
PFA≥16 | Identified as pa+ + with ++ + |
The test samples of the test experiment are the sun-proof milk prepared in examples 1-7 and comparative examples 1-6, respectively, and the sun-proof effect of the product is tested according to the sun-proof cosmetic sun-proof index test method (human body method) of cosmetic safety technical Specification (2015 edition), and the test results are shown in the table.
Sensory evaluation
Since the sun protection milk is mostly female, 39 female volunteers are selected, with ages between 22 and 40, and all volunteers have no history of skin allergy. The volunteers can use the products according to the specifications, and complete the evaluation work according to the requirements by matching with staff, so that the volunteers have certain expression capability and can truly respond to the experience after use. The sun protection milks prepared in examples 1 to 7 and comparative examples 1 to 6 were each randomly given to volunteers, who were allowed to use the specified sun protection milk daily for 14 days continuously, and the protective milk used was subjected to sensory evaluation, for example. The evaluation items include greasy feel, heavy feel, and whiteness. The evaluation criteria used a10 minute scale, with a higher score representing a higher degree of skin feel or appearance blushing of the sample.
Crystallization precipitation: weighing crystalline ultraviolet absorber (other materials except polysiloxane-15 in oil solubility are all crystalline sunscreen agents; in addition, water solubility and particles are not crystalline) and mixing the rest materials of oil phase; heating at 80-85 deg.c for 5-15 min, dissolving to clear and transparent, and cooling to 40-45 deg.c to obtain oil phase mixture.
1. The experimental method comprises the following steps: the oil phase mixtures of examples 1 to 7 and comparative examples 1 to 6 were examined for stability by placing the prepared compositions in an environment of 5℃for 1 month, respectively, and observing the precipitation.
Table 4 evaluation results of sunscreen compositions of examples 1-7
Example 1 | Example 2 | Example 3 | Example 4 | Example 5 | Example 6 | Example 7 | |
SPF | 20.7 | 20.9 | 24.6 | 46.3 | 45.3 | 49.3 | 52.8 |
PA | ++ | ++ | ++ | +++ | +++ | +++ | +++ |
Whether or not crystallization occurs under low temperature conditions | Is that | Whether or not | Whether or not | Whether or not | Whether or not | Whether or not | Whether or not |
Greasy feel | Not greasy | Greasiness of | Refreshing and cool | Greasiness of | Not greasy | Not greasy | Not greasy |
Sense of heaviness | Light and thin | Heavy weight | Light and thin | Heavy weight | Light and thin | Light and thin | Light and thin |
Pan whiteness | Transparent and transparent | Transparent and transparent | No whitening | No whitening | No whitening | No whitening | Transparent and transparent |
Table 5 evaluation results of sunscreen compositions of comparative examples 1-6
Comparative example 1 | Comparative example 2 | Comparative example 3 | Comparative example 4 | Comparative example 5 | Comparative example 6 | |
SPF | 20.9 | 11.9 | 26.6 | 20.2 | 32.3 | 29.4 |
PA | ++ | ++ | + | ++ | ++ | +++ |
Whether or not crystallization occurs under low temperature conditions | Whether or not | Whether or not | Whether or not | Whether or not | Is that | Is that |
Greasy feel | Not greasy | Not greasy | Not greasy | Not greasy | Not greasy | Not greasy |
Sense of heaviness | Light and thin | Light and thin | Heavy weight | Light and thin | Light and thin | Light and thin |
Pan whiteness | Transparent and transparent | No whitening | Whitening off | No whitening | No whitening | No whitening |
As shown in tables 4 and 5, when the comparative example 1 is compared with example 1, the sunscreen efficiency of the macromolecular sunscreen agent is higher, and the irritation and greasy feeling caused by the sunscreen agent can be reduced by using a low amount of the macromolecular sunscreen agent; the data of comparative examples 2-4 show that the pure titanium dioxide has better UVB resistance than zinc oxide, and the zinc oxide has better UVA protection than titanium dioxide, but the addition of 10% of titanium dioxide content has reduced the use feeling of partial consumers and serious whitening, the transparency of zinc oxide is better, and the skin feel is lighter and thinner. The data of example 2 and comparative examples 5-6 show that the macromolecular organic sunscreen agent can greatly improve SPF and PA values, and increases with the increase of the content; meanwhile, the sticky feeling of the cosmetics can be reduced by adding a small amount of the cosmetics, and the experience is improved; the C12-15 alcohol benzoate and caprylic/capric triglyceride have excellent solubility in crystalline chemical sunscreens. Examples 3-6 as compared to comparative example 1, it can be seen that the addition of the film former helps to form a continuous and uniform film on the skin, thereby enhancing the sun protection effect.
The data of examples 4-7 demonstrate that increasing levels of titanium dioxide, increasing SPF values in cosmetics, but excessive levels result in decreased consumer use; the content of ethylhexyl triazone and bis-ethylhexyl oxyphenol methoxyphenyl triazine is increased, the SPF value of the cosmetic is increased, but excessive content requires a large amount of grease to be dissolved, so that the sticky feel of the cosmetic is improved, and the experience of consumers is reduced. The content of titanium dioxide in the inorganic component is favorable for improving the SPF value, the content of zinc oxide is favorable for improving the PA value, and the addition of the large molecular weight organic sun-screening agent can simultaneously improve the values of the inorganic component and the zinc oxide, so that the ultraviolet UVB-UVA full-segment protection is formed.
The invention provides a macromolecular organic sun-screening composition, which is formed by mixing one or a combination of macromolecular organic ultraviolet absorbent, inorganic ultraviolet screening agent nano titanium dioxide and nano zinc oxide and other cosmetically acceptable components, is safe and nontoxic, and can carry out photothermal conversion on absorbed ultraviolet while scattering the ultraviolet; in addition, the macromolecular organic ultraviolet absorbent has better light stability, safety and high efficiency, so that the cosmetics are easy to spread and disperse, the sticky feeling is reduced, and the application field of the cosmetics is enlarged.
The above examples of the present invention are only examples for clearly illustrating the present invention, and are not limiting of the embodiments of the present invention. Other variations or modifications of the above teachings will be apparent to those of ordinary skill in the art. It is not necessary here nor is it exhaustive of all embodiments. Any modification, equivalent replacement, improvement, etc. which come within the spirit and principles of the invention are desired to be protected by the following claims.
Claims (10)
1. A sunscreen composition comprising, by weight:
1% of diethyl hexyl butyramide triazinone,
2% Of bis-ethylhexyloxyphenol methoxyphenyl triazine,
Polysiloxane-15 wt%,
1.5 Percent of ethylhexyl triazone,
Zinc oxide/triethoxyoctylsilane 5%, titanium dioxide/triethoxyoctylsilane 3%,
Caprylic/capric triglyceride 5%, isopropyl palmitate 8%, C12-15 alcohol benzoate 5%, trimethylsiloxysilicate 1.5%, and the sunscreen composition as a sunscreen ingredient contains only large molecular weight and has a molecular weight greater than 500 daltons.
2. The sunscreen composition of claim 1, further comprising one or more of an emulsifier, a thickener, a humectant, a chelating agent, a preservative, a skin conditioning agent, a fragrance, a pH adjusting agent, and a solvent.
3. A sunscreen composition according to claim 2, wherein said emulsifier is selected from one or more of PEG-9 dimethicone ethyl dimethicone, polyglycerol-3 dimethicone hydroxyethyl dimethicone, lauryl polyethylene glycol/polypropylene glycol-18/18-dimethicone, PEG-10 dimethicone, polyglycerol-3 polyricinoleate, polyglycerol-3 diisostearate.
4. A sunscreen composition according to claim 2, wherein said emulsifier is selected from the group consisting of PEG-9 polydimethylsiloxane ethyl polydimethylsiloxane and PEG-10 polydimethylsiloxane.
5. A sunscreen composition according to claim 2, wherein said thickener is selected from one or more of disteardimethylammonium hectorite, silica silylate, dextrin palmitate.
6. A sunscreen composition according to claim 2, wherein said thickener is selected from the group consisting of distearyldimethylammonium hectorite.
7. A sunscreen composition according to claim 2, wherein said pH modifier is selected from one or more of arginine, sodium hydroxide, potassium hydroxide, triethanolamine, aminomethylpropanol.
8. Use of a sunscreen composition according to any of claims 1 to 7 for the preparation of a sunscreen cosmetic.
9. The use according to claim 8, wherein the sunscreen cosmetic is selected from any one of sun cream, sun lotion, sun cream, sun liquid, sun spray, sun gel, barrier cream, barrier lotion, BB cream.
10. A method of preparing a sunscreen composition according to any of claims 1 to 7, comprising the step of mixing the components.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210593580.4A CN115024994B (en) | 2022-05-27 | 2022-05-27 | High-safety sun-screening composition and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210593580.4A CN115024994B (en) | 2022-05-27 | 2022-05-27 | High-safety sun-screening composition and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115024994A CN115024994A (en) | 2022-09-09 |
CN115024994B true CN115024994B (en) | 2024-07-16 |
Family
ID=83121148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210593580.4A Active CN115024994B (en) | 2022-05-27 | 2022-05-27 | High-safety sun-screening composition and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115024994B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116473861A (en) * | 2022-12-21 | 2023-07-25 | 上海研绎科技发展有限公司 | Sun-screening agent composition, preparation method, application and sun-screening product |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109820738A (en) * | 2019-03-29 | 2019-05-31 | 广东芭薇生物科技股份有限公司 | A kind of high power oil-in-water type sunscreen cosmetic |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106265136A (en) * | 2016-10-14 | 2017-01-04 | 上海新高姿化妆品有限公司 | A kind of efficient sun-proof CC cream composition of frivolous patch skin |
CN111150677B (en) * | 2020-02-25 | 2022-09-13 | 广州玮弘祺生物科技有限公司 | Sunscreen cosmetic and preparation method thereof |
CN113425649A (en) * | 2021-08-12 | 2021-09-24 | 广州集妍化妆品科技有限公司 | Sunscreen synergistic composition, cosmetic composition and preparation method thereof |
CN114404330A (en) * | 2021-12-27 | 2022-04-29 | 广州市第二中学 | Sunscreen composition and preparation method thereof |
-
2022
- 2022-05-27 CN CN202210593580.4A patent/CN115024994B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109820738A (en) * | 2019-03-29 | 2019-05-31 | 广东芭薇生物科技股份有限公司 | A kind of high power oil-in-water type sunscreen cosmetic |
Also Published As
Publication number | Publication date |
---|---|
CN115024994A (en) | 2022-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110279605B (en) | Sunscreen composition | |
CN115282073B (en) | Composition and sun-screening cosmetic | |
CN110559197B (en) | Sunscreen lotion and preparation method thereof | |
CN106176259B (en) | Sunscreen cream with double isolation and after-sun repair effects | |
CN109908004B (en) | Multiple emulsion sunscreen cosmetic and preparation method thereof | |
CN116139064B (en) | Sun-proof synergistic composition, application thereof and cosmetics | |
CN112516022A (en) | Sun-screening lotion and preparation method thereof | |
CN115969749A (en) | Sunscreen composition and preparation method thereof | |
CN115024994B (en) | High-safety sun-screening composition and preparation method and application thereof | |
CN108014060B (en) | Sunscreen synergistic composition and application thereof | |
JP3582936B2 (en) | External preparation for skin | |
CN114053202A (en) | Sunscreen composition and sunscreen agent | |
CN113425649A (en) | Sunscreen synergistic composition, cosmetic composition and preparation method thereof | |
AU714104B2 (en) | Substituted o-aminocarbonylbenzoic acid salts and their use as sunscreens | |
CN111991257A (en) | Sunscreen synergistic composition and application thereof in preparation of cosmetics | |
CN116059127B (en) | Natural sun-screening composition and preparation method and application thereof | |
CN116672279A (en) | Fresh and stable high-multiple sun-screening emulsion and preparation method thereof | |
US20220168209A1 (en) | Sunscreen Compositions | |
CN113476319A (en) | Sunscreen repair composition and preparation method thereof | |
Reddy et al. | Sunscreens: Developments and challenges | |
JP3582935B2 (en) | External preparation for skin | |
CN105030571B (en) | A kind of pure physical sunscreen breast and preparation method thereof | |
US20130266525A1 (en) | High protection uva/uvb composition and topical cosmetic composition | |
CN114557917B (en) | Sun-proof cosmetic composition | |
JP3582937B2 (en) | External preparation for skin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |